Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
about
NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomasMicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2Profiling critical cancer gene mutations in clinical tumor samplesHuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastomaMIBG scintigraphy and PET imaging for diagnosing neuroblastomaAssociation of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3'-end processing of pre-MRNA.AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomasMutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastomas and in normal developmentSmall molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastomaHuman proto-oncogene N-myc encodes nuclear proteins that bind DNAIntrachromosomal rearrangements fusing L-myc and rlf in small-cell lung cancerRox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.Amplification of a DEAD box protein gene in retinoblastoma cell linesIdentification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsetsMechanisms of multistep carcinogenesis and carcinogen risk assessmentA novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancerN-myc amplification in multiple homogeneously staining regions in two human neuroblastomasAmplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNANeuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaMolecular cloning and primary structure of human glial fibrillary acidic proteinAlternative processing of RNA transcribed from NMYCLithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cellsNucleotide sequence of the 3' exon of the human N-myc geneThe human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAsNucleotide sequence of the human N-myc geneOutcome after reduced chemotherapy for intermediate-risk neuroblastomaN-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factorCorrelation of elevated level of blood midkine with poor prognostic factors of human neuroblastomasAmplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomasRegulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous SystemTranslational development of difluoromethylornithine (DFMO) for the treatment of neuroblastomaEnergy metabolism in neuroblastoma and Wilms tumorCell Proliferation in NeuroblastomaNeuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosisMYC and metabolism on the path to cancerMultidrug resistance and cancer stem cells in neuroblastoma and hepatoblastomaFunctional interactions among members of the MAX and MLX transcriptional network during oncogenesisPreclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastomaTime-lapse imaging of neuroblastoma cells to determine cell fate upon gene knockdown
P2860
Q21092404-D56C61A0-6F2B-4033-9774-8D10AA6EC1F1Q21245700-BBC57B89-0151-422E-88C3-55B9FADC84D2Q21562343-D28D2637-6773-49E5-86D6-6B86E69BBC3AQ22009918-AC7E3CAD-D944-4CBD-B0C3-C5BF832D77A2Q24186888-5A5653B8-1E54-40D7-8789-70357AF20D1EQ24234571-35FDB083-B25E-43BE-AF6F-891E1577905DQ24291792-662AA8C0-43F5-4FDD-B61D-FEC848BE503CQ24294176-DE88AD40-413F-43ED-BE35-B0F7A29FF064Q24294757-6DF75CD8-CCF9-4227-9DE4-5A4B8E4F43FDQ24296639-9C346010-7468-43C5-AAB2-15CAB921A647Q24299897-12D9481E-2F7C-434C-8F9C-25FA9FF8AE0EQ24305387-9255BDEA-F9EB-4665-89BF-91B8977B7541Q24310015-ED8F858E-642E-48F0-AA63-597ED8E7370CQ24310436-61E6BDBD-365A-4FDD-96E2-5D0E19345648Q24545293-4E76C6D5-449D-4526-9939-8F2292C07422Q24554416-E0D3391E-8769-4598-9038-52D3DCC7E12AQ24555635-B9762803-0AFC-4BC4-AD47-A518539D1188Q24567721-B3078B3F-A176-4CC3-ACB5-96EAE22B0BA8Q24568308-F9BBCD13-A051-4463-B043-14BE941974E3Q24594695-AA587D0D-A575-4B51-BE7F-754C1BB1220FQ24611923-88716C07-1CC3-41D9-9EE0-CD135FB6B77CQ24613262-119E0BA4-5F39-4C14-AD85-7B1B0FC40051Q24617423-E8145D18-021E-4B16-AD14-CCE7C1C78F06Q24623960-A1D7FFF5-4919-480E-A07B-D7AED64D1DFEQ24627389-B4E02E5C-5764-4DD6-90A7-4B47429A3058Q24632077-10393192-EB6A-4AFD-BB52-6982EB6B835DQ24633964-38D6B729-C395-4CD4-AC52-39651313CC53Q24656221-7C4122C4-CB5F-459C-A57B-9C494C06F351Q24656678-C6C7BDD1-0C1A-4A87-B5DC-7C09A91F552EQ24684274-6A364DAD-460B-4C46-A4AE-5DA2AA24D07EQ26744719-343F6235-1205-406A-A64D-1B56EB481E03Q26770306-2FE76A0C-CD04-4FE2-9B6D-FABD7D8C051DQ26770341-E1AA174E-95B6-4425-8C1B-C984E526FABEQ26771708-0B5F4B06-A564-4F59-A6EC-23962FFBE91EQ26774960-C3D60085-AAD6-4405-BD03-CEDFF7672A48Q26798086-730A2E82-0431-4D17-A0CE-ADACC612494DQ26822652-9A9483DF-6067-4A3C-B8CA-4DFD0400F8ADQ26853567-8E302FE0-D294-4476-A953-B0B8684E1C17Q27303714-8FF98FFE-A15B-40EF-A98E-3584477A4516Q27332436-85D8A7B7-ADC4-4BB2-B94D-E02C21FAC907
P2860
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
description
1984 nî lūn-bûn
@nan
1984 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Amplification of N-myc in untr ...... es with advanced disease stage
@ast
Amplification of N-myc in untr ...... es with advanced disease stage
@en
Amplification of N-myc in untr ...... es with advanced disease stage
@nl
type
label
Amplification of N-myc in untr ...... es with advanced disease stage
@ast
Amplification of N-myc in untr ...... es with advanced disease stage
@en
Amplification of N-myc in untr ...... es with advanced disease stage
@nl
prefLabel
Amplification of N-myc in untr ...... es with advanced disease stage
@ast
Amplification of N-myc in untr ...... es with advanced disease stage
@en
Amplification of N-myc in untr ...... es with advanced disease stage
@nl
P2093
P3181
P356
P1433
P1476
Amplification of N-myc in untr ...... es with advanced disease stage
@en
P2093
P304
P3181
P356
10.1126/SCIENCE.6719137
P407
P577
1984-06-08T00:00:00Z